If you need your mode of transportation to provide more than just a spacious interior, there are a host of brilliant 4x4 SUVs on sale. Some are equipped for only lighter off-road ventures ...

There was an error generating the full edition PDF. Please try again later. Click and hold your mouse button on the page to select the area you wish to save or print ...

The landscape of Indian business is constantly evolving, with mergers and amalgamations (M&A) serving as pivotal strategies for companies seeking accelerated growth, expanded market presence, and ...

ICICI Securities has 'buy' call on Suven Pharma, target Rs 1,400 ICICI Securities has a 'buy' rating on Suven Pharmaceuticals shares with a target price of Rs 1,400 apiece. ICICI Securities has 'buy' ...

Indian pharmaceutical companies are crucial to the U.S. healthcare system, filling four out of every ten prescriptions in 2022. Reports indicate that Indian medicines saved the U.S. healthcare system ...

On 7 April 2025 at the American Academy of Neurology (AAN) 2025 annual meeting held in San Diego, California, Axsome Therapeutics presented efficacy and safety data from the Phase III ACCORD-2 ...

Suven Pharmaceuticals Limited was established in 2018 and specializes in developing and manufacturing NCE-based intermediates, APIs, and formulated drugs. It operates as a CDMO, leveraging expertise ...

Brokerage firm Goldman Sachs on Tuesday, April 8, initiated coverage on two pharma stocks — Suven Pharma Ltd. and Piramal Pharma Ltd. The brokerage initiated coverage with a "buy" rating on Suven ...

Goldamn Sachs has initiated coverage of two Indian pharmaceuticals, Suven Pharma and Piramal Pharma, rating the stocks as a 'Buy' for its first rating. The brokerage has cited the reasons behind ...